Moderna, Inc. (MRNA)
NASDAQ · Healthcare
Moderna, Inc. Total Liabilities 2016–2025
Moderna, Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Moderna, Inc. total liabilities as of December 31, 2025: 3.69B, a 13.79% increase year-over-year.
- Moderna, Inc. total liabilities for 2025 were 3.69B, a 13.79% increase from 2024.
- Moderna, Inc. total liabilities for 2024 were 3.24B, a 29.11% decrease from 2023.
- Moderna, Inc. total liabilities for 2023 were 4.57B, a 32.12% decrease from 2022.
- Moderna, Inc. total liabilities for 2022 were 6.74B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Moderna, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3,688 |
| 2024 | $3,241 |
| 2023 | $4,572 |
| 2022 | $6,735 |
| 2021 | $10,524 |
| 2020 | $4,776 |
| 2019 | $415 |
| 2018 | $432 |
| 2017 | $459 |
Moderna Inc. Total Liabilities — FAQ
Moderna Inc. (MRNA) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRNA's total liabilities history?
The chart and table above show Moderna Inc.'s total liabilities by year and by quarter, including the growth rate.